Sclerochorioretinal abnormalities in hypercholesterolemic rabbits treated with rosiglitazone

Area of Science:

• Ophthalmology
• Histology
• Pharmacology

Background:

• Hypercholesterolemia can induce early ocular abnormalities.
• The effects of a hypercholesterolemic diet on retinal, choroidal, and scleral tissues are not fully understood.
• Investigating preventative measures is crucial for ocular health.

Purpose of the Study:

• To evaluate early retinal, choroidal, and scleral abnormalities induced by a hypercholesterolemic diet in rabbits.
• To assess the preventative effects of rosiglitazone on these diet-induced abnormalities.
• To understand the potential of rosiglitazone in preserving ocular structural integrity.

Main Methods:

• Fifty-four New Zealand rabbits were allocated to control, hypercholesterolemic diet, and two rosiglitazone treatment groups.
• Histologic and histomorphometric analyses were performed on sclera and choroid.
• Immunohistochemical analysis of the retina was conducted using anti-calretinin and anti-glial fibrillary acidic protein (GFAP) antibodies.

Main Results:

• Hypercholesterolemic diet significantly increased scleral and choroidal thickness.
• Increased calretinin immunoreactivity was observed in rabbits on a hypercholesterolemic diet.
• Rosiglitazone administration, regardless of timing, showed a protective effect, preserving structural anatomy and reducing abnormalities.

Conclusions:

• A hypercholesterolemic diet induces early structural abnormalities in the retina, choroid, and sclera.
• Rosiglitazone demonstrates a significant protective role in preventing these diet-induced ocular changes.
• The findings suggest rosiglitazone's potential therapeutic value in managing diet-related ocular conditions.